SPOTLIGHT -
Patient case 2: DME Patient Treated with Ranibizumab Biosimilar
Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Read More
Patient case 1: Neovascular AMD Patient Treated with Ranibizumab Biosimilar
Patient Cases Treated with a Ranibizumab Biosimilar
Dilsher Dhoot, MD, presents two cases involving DME and CRVO, that show remarkable anatomical improvement with a biosimilar comparable to those achieved with reference biologics.
Biosimilars in Retinal Diseases
Dilsher Dhoot, MD, provides an overview of biosimilars in retinal diseases and discusses how he identifies patients suitable for biosimilar therapy.
Future Directions of Retinal Eye Disorders
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.
Barriers to Co-Management of Retinal Eye Disorders
Key opinion leaders discuss the barriers to co-management of retinal eye disease.
Retinal Eye Disorders: Co-Management Transition of Care
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the transition of care from ophthalmologist to optometrist once a patient has completed active treatment for retinal eye disease.
Anti-VEGF for the Treatment of Retinal Eye Disorders
Experts in the field of retinal eye disorders discuss the role of injectable anti-VEGF inhibitors and how they have changed the treatment landscape.
Treatment Landscape of Retinal Eye Disorders
Dilsher S. Dhoot, MD, leads a discussion about the treatment landscape of retinal eye disorders.
Retinal Eye Disorders: Co-Management and Patient Relationships
Key opinion leaders discuss how co-management affects the patient-provider relationship in the treatment of retinal eye disorders.
Co-Management of Retinal Eye Disorders
A. Paul Chous, MA, OD, FAAO, leads a discussion about the optimal circumstances for optometrists and ophthalmologists to work together to manage a patient with retinal eye disorders.
Retinal Eye Disorders: COVID-19 and Telemedicine
Experts in the field of retinal eye disorders discuss how the COVID-19 pandemic and use of telemedicine has affected communication between optometrists, ophthalmologists, patients, and providers.
Retinal Eye Disorders: Patient Education and Communication
Experts in the field of retinal eye disorders talk about the role of ophthalmologists and optometrists in regard to patient education and communication.
AAO Guidelines and Retinal Eye Disorder Treatment
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the American Academy of Ophthalmology (AAO) guidelines on co-management between optometrists and ophthalmologists in retinal eye disorders.
Challenges of Co-Management of Retinal Eye Disorders
Experts discuss the challenges regarding the treatment of retinal disorders, and how co-management can potentially address those challenges.
Clinical Overview of Retinal Disorders
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the co-management of retinal eye disorders and provide a clinical overview of the disease.